• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

给药透析期间的腹膜血流量和腹膜转运参数。

Peritoneal blood flow and peritoneal transfer parameters during dialysis with administration of drugs.

作者信息

Grzegorzewska A E, Antoniewicz K

机构信息

Department of Nephrology, Karol Marcinkowski University School of Medical Sciences, Poznan, Poland.

出版信息

Adv Perit Dial. 1995;11:28-32.

PMID:8534723
Abstract

Effective peritoneal capillary blood flow (EPBF) was evaluated by calculating the diffusive mass transport coefficient of carbon dioxide during intermittent peritoneal dialysis (IPD) performed with the intraperitoneal administration of sodium nitroprusside (NP), chlorpromazine (CP), or isoproterenol (IP) in the doses 5, 2.5, and 0.5 mg/L, respectively. Peritoneal transfer rates of substances of different molecular size and charge were simultaneously examined and compared with EPBF. EPBF (mL/min) was 220 +/- 40 (+/- SEM) for NP (n = 11), 224 +/- 29 for CP (n = 10), and 243 +/- 35 for IP (n = 10). These values did not differ significantly from those obtained during dialysis without drugs (223 +/- 22 mL/min, n = 20). NP, CP, and IP did not cause any significant changes in peritoneal transfer of carbon dioxide. Transfer rates of bicarbonate and total carbon dioxide were increased only with NP. All drugs enhanced the peritoneal removal of sodium, potassium, urea, and uric acid. Total protein loss was enhanced by all drugs except IP. With statistically similar EPBF during dialysis, the augmenting effect of NP and IP on small solute removal was the most pronounced. These results indicate that EPBF is not a major factor in the changes in peritoneal transfer rates during dialysis performed with NP, CP, or IP.

摘要

通过计算在分别以5 mg/L、2.5 mg/L和0.5 mg/L的剂量腹腔内给予硝普钠(NP)、氯丙嗪(CP)或异丙肾上腺素(IP)进行间歇性腹膜透析(IPD)期间二氧化碳的扩散质量传输系数,评估有效腹膜毛细血管血流量(EPBF)。同时检测不同分子大小和电荷的物质的腹膜转运率,并与EPBF进行比较。NP组(n = 11)的EPBF(mL/min)为220±40(±SEM),CP组(n = 10)为224±29,IP组(n = 10)为243±35。这些值与无药物透析期间获得的值(223±22 mL/min,n = 20)无显著差异。NP、CP和IP均未引起二氧化碳腹膜转运的任何显著变化。仅NP使碳酸氢盐和总二氧化碳的转运率增加。所有药物均增强了钠、钾、尿素和尿酸的腹膜清除。除IP外,所有药物均增加了总蛋白丢失。在透析期间EPBF在统计学上相似的情况下,NP和IP对小溶质清除的增强作用最为明显。这些结果表明,EPBF不是NP、CP或IP透析期间腹膜转运率变化的主要因素。

相似文献

1
Peritoneal blood flow and peritoneal transfer parameters during dialysis with administration of drugs.给药透析期间的腹膜血流量和腹膜转运参数。
Adv Perit Dial. 1995;11:28-32.
2
[Peritoneal blood flow and peritoneal transfer parameters during intermittent peritoneal dialyses performed with administration of sodium nitroprusside or chlorpromazine].[使用硝普钠或氯丙嗪进行间歇性腹膜透析时的腹膜血流量和腹膜转运参数]
Przegl Lek. 1996;53(5):412-6.
3
Effective peritoneal capillary blood flow and peritoneal transfer parameters.
Adv Perit Dial. 1993;9:8-11.
4
[Peritoneal blood flow, peritoneal transfer and continuous ambulatory peritoneal dialysis].[腹膜血流、腹膜转运与持续性非卧床腹膜透析]
Pol Merkur Lekarski. 1997 Sep;3(15):122-5.
5
[Measuring ionized calcium (Ca2+) transport during intermittent peritoneal dialysis (IPD)].[间歇性腹膜透析期间测量离子钙(Ca2+)转运]
Przegl Lek. 1997;54(5):302-7.
6
Correlation between effective peritoneal blood flow, blood pressure, and peritoneal transfer rates.有效腹膜血流量、血压与腹膜转运率之间的相关性。
Adv Perit Dial. 1996;12:19-23.
7
Peritoneal filtration fraction (PFF).腹膜滤过分数(PFF)。
Adv Perit Dial. 1994;10:30-2.
8
Effective peritoneal blood flow (EPBF) and patient characteristics.有效腹膜血流(EPBF)与患者特征
Adv Perit Dial. 1994;10:27-9.
9
Arterial blood pressure and effective peritoneal blood flow during intermittent peritoneal dialysis.间歇性腹膜透析期间的动脉血压和有效腹膜血流量
Pol J Pharmacol. 1996 Jan-Feb;48(1):99-103.
10
Vasodilatation by intraperitoneal addition of nitroprusside is not a model for high peritoneal transport.腹腔内注入硝普钠引起的血管舒张并非高腹膜转运的模型。
Adv Perit Dial. 1999;15:53-9.

引用本文的文献

1
Celiac disease and lymphoma risk: a multicentric case--control study in Spain.
Dig Dis Sci. 2004 Mar;49(3):408-12. doi: 10.1023/b:ddas.0000020494.79480.30.